NCT04450017View on ClinicalTrials.gov

Clinical Features of Severe Patients With COVID-19

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 6, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
SARS-CoV2
Interventions
DIAGNOSTIC_TEST

The demographic, clinical, laboratory, and instrumental data

Measurement of the demographic, clinical data, laboratory data, and instrumental data

Trial Locations (1)

115682

Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow

All Listed Sponsors
lead

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

OTHER_GOV

NCT04450017 - Clinical Features of Severe Patients With COVID-19 | Biotech Hunter | Biotech Hunter